SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-374827
Filing Date
2013-09-23
Accepted
2013-09-23 17:06:07
Documents
7
Period of Report
2013-09-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d601298d8k.htm 8-K 36334
2 EX-10.1 d601298dex101.htm EX-10.1 122282
3 EX-10.2 d601298dex102.htm EX-10.2 63614
4 EX-10.3 d601298dex103.htm EX-10.3 66557
5 EX-10.4 d601298dex104.htm EX-10.4 64282
6 EX-10.5 d601298dex105.htm EX-10.5 40536
7 EX-10.6 d601298dex106.htm EX-10.6 43121
  Complete submission text file 0001193125-13-374827.txt   438215
Mailing Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 131110609
SIC: 2835 In Vitro & In Vivo Diagnostic Substances